Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 224

1.

Relationship between immunity to Borrelia burgdorferi outer-surface protein A (OspA) and Lyme arthritis.

Steere AC, Drouin EE, Glickstein LJ.

Clin Infect Dis. 2011 Feb;52 Suppl 3:s259-65. doi: 10.1093/cid/ciq117. Review.

2.

Antibiotic-refractory Lyme arthritis is associated with HLA-DR molecules that bind a Borrelia burgdorferi peptide.

Steere AC, Klitz W, Drouin EE, Falk BA, Kwok WW, Nepom GT, Baxter-Lowe LA.

J Exp Med. 2006 Apr 17;203(4):961-71. Epub 2006 Apr 3.

3.

Evaluation of OspA vaccination-induced serological correlates of protection against Lyme borreliosis in a mouse model.

Schwendinger MG, O'Rourke M, Traweger A, Savidis-Dacho H, Pilz A, Portsmouth D, Livey I, Barrett PN, Crowe BA.

PLoS One. 2013 Nov 18;8(11):e79022. doi: 10.1371/journal.pone.0079022. eCollection 2013.

4.

HLA type and immune response to Borrelia burgdorferi outer surface protein a in people in whom arthritis developed after Lyme disease vaccination.

Ball R, Shadomy SV, Meyer A, Huber BT, Leffell MS, Zachary A, Belotto M, Hilton E, Bryant-Genevier M, Schriefer ME, Miller FW, Braun MM.

Arthritis Rheum. 2009 Apr;60(4):1179-86. doi: 10.1002/art.24418.

5.

HLA-DR alleles determine responsiveness to Borrelia burgdorferi antigens in a mouse model of self-perpetuating arthritis.

Iliopoulou BP, Guerau-de-Arellano M, Huber BT.

Arthritis Rheum. 2009 Dec;60(12):3831-40. doi: 10.1002/art.25005.

6.

Human homologues of a Borrelia T cell epitope associated with antibiotic-refractory Lyme arthritis.

Drouin EE, Glickstein L, Kwok WW, Nepom GT, Steere AC.

Mol Immunol. 2008 Jan;45(1):180-9. Epub 2007 Jun 6.

7.

Reservoir targeted vaccine for lyme borreliosis induces a yearlong, neutralizing antibody response to OspA in white-footed mice.

Meirelles Richer L, Aroso M, Contente-Cuomo T, Ivanova L, Gomes-Solecki M.

Clin Vaccine Immunol. 2011 Nov;18(11):1809-16. doi: 10.1128/CVI.05226-11. Epub 2011 Sep 14.

8.

Identification of a defined linear epitope in the OspA protein of the Lyme disease spirochetes that elicits bactericidal antibody responses: Implications for vaccine development.

Izac JR, Oliver LD Jr, Earnhart CG, Marconi RT.

Vaccine. 2017 May 31;35(24):3178-3185. doi: 10.1016/j.vaccine.2017.04.079. Epub 2017 May 4.

9.

An effective second-generation outer surface protein A-derived Lyme vaccine that eliminates a potentially autoreactive T cell epitope.

Willett TA, Meyer AL, Brown EL, Huber BT.

Proc Natl Acad Sci U S A. 2004 Feb 3;101(5):1303-8. Epub 2004 Jan 23.

10.

A new approach to a Lyme disease vaccine.

Livey I, O'Rourke M, Traweger A, Savidis-Dacho H, Crowe BA, Barrett PN, Yang X, Dunn JJ, Luft BJ.

Clin Infect Dis. 2011 Feb;52 Suppl 3:s266-70. doi: 10.1093/cid/ciq118.

PMID:
21217174
11.

Infection of mice with lyme disease spirochetes constitutively producing outer surface proteins a and B.

Strother KO, Hodzic E, Barthold SW, de Silva AM.

Infect Immun. 2007 Jun;75(6):2786-94. Epub 2007 Mar 19.

13.

Autoimmune mechanisms in antibiotic treatment-resistant lyme arthritis.

Steere AC, Gross D, Meyer AL, Huber BT.

J Autoimmun. 2001 May;16(3):263-8. Review.

PMID:
11334491
17.
18.

Clonal diversification in OspA-specific antibodies from peripheral circulation of a chronic Lyme arthritis patient.

Ghosh S, Huber BT.

J Immunol Methods. 2007 Apr 10;321(1-2):121-34. Epub 2007 Feb 6.

19.

Reductions in human Lyme disease risk due to the effects of oral vaccination on tick-to-mouse and mouse-to-tick transmission.

Voordouw MJ, Tupper H, Önder Ö, Devevey G, Graves CJ, Kemps BD, Brisson D.

Vector Borne Zoonotic Dis. 2013 Apr;13(4):203-14. doi: 10.1089/vbz.2012.1003. Epub 2013 Feb 21.

20.

Serum reactivity against Borrelia burgdorferi OspA in patients with rheumatoid arthritis.

Hsieh YF, Liu HW, Hsu TC, Wei JC, Shih CM, Krause PJ, Tsay GJ.

Clin Vaccine Immunol. 2007 Nov;14(11):1437-41. Epub 2007 Sep 19.

Supplemental Content

Support Center